Search results
Results from the WOW.Com Content Network
The statewide regulator for marijuana is the Oklahoma Medical Marijuana Authority. Under SQ 788, an individual who obtains a Medical Marijuana License from the state of Oklahoma may consume marijuana legally and may legally possess up to: 3 ounces (85 g) of marijuana; 6 mature marijuana plants (defined as plants that are in the budding stage)
Oklahoma voters authorized the state’s medical marijuana program in 2018, and since then, hundreds of thousands of medical marijuana licenses have been issued in Oklahoma
Oklahoma does not have a list of qualifying conditions for people seeking a medical marijuana license. Doctors are allowed to recommend patients if they think medical marijuana is a good treatment ...
The medical marijuana industry in Oklahoma is changing, business licenses plunging and the market shrinking. Skip to main content. 24/7 Help. For premium support please call: 800-290-4726 more ...
Oklahoma Question 788, the Oklahoma Medical Marijuana Legalization Initiative, was a 2018 ballot measure on the June 26 ballot (alongside primaries for various statewide offices) to legalize medical marijuana in the state of Oklahoma. It passed with over 56% "yes" votes.
The Justice Department has enforced this policy through various means, including criminal prosecutions, civil asset forfeiture, and paramilitary-style raids targeting medical cannabis providers, and various penalties threatened or initiated against other individuals involved in state-legal medical cannabis activities (doctors, landlords, state ...
Oklahoma's medical marijuana industry has been exploding. Lawmakers have extended a moratorium on new licenses. Oklahoma's moratorium on new medical marijuana business licenses extended two more years
A medical cannabis card in California. A medical cannabis card or medical marijuana card is a state-issued identification card that enables a patient with a doctor's recommendation to obtain, possess, or cultivate cannabis for medicinal use despite marijuana's lack of the normal Food and Drug Administration testing for safety and efficacy.